Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease - Wikidata - awgldk - TriplyDB

Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease

Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease

http://www.wikidata.org/entity/Q33952130

about

The promise of neuroprotective agents in Parkinson's disease Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor- alpha Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease Attenuation of oxidative stress, inflammation and apoptosis by minocycline prevents retrovirus-induced neurodegeneration in mice Posterior cingulum white matter disruption and its associations with verbal memory and stroke risk in mild cognitive impairment Delayed minocycline but not delayed mild hypothermia protects against embolic stroke Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent Perspectives The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disorders The neuroimmunology of schizophrenia Profile of minocycline and its potential in the treatment of schizophrenia Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity Attenuation of pathogenic immune responses during infection with human and simian immunodeficiency virus (HIV/SIV) by the tetracycline derivative minocycline The yin and yang of microglia Immunomodulators as Therapeutic Agents in Mitigating the Progression of Parkinson's Disease Recent advances in methamphetamine neurotoxicity mechanisms and its molecular pathophysiology Effects of 6-hydroxydopamine exposure on motor activity and biochemical expression in zebrafish (Danio rerio) larvae Minocycline modulates human social decision-making: possible impact of microglia on personality-oriented social behaviors Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)alpha/betaII FcRγ-dependent immune activation initiates astrogliosis during the asymptomatic phase of Sandhoff disease model mice Protective Effect of Minocycline Against Ketamine-Induced Injury in Neural Stem Cell: Involvement of PI3K/Akt and Gsk-3 Beta Pathway.Role of interleukin-1beta in postoperative cognitive dysfunction.A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results The Protective Effect of Minocycline in a Paraquat-Induced Parkinson's Disease Model in Drosophila is Modified in Altered Genetic Backgrounds.Missing and Possible Link between Neuroendocrine Factors, Neuropsychiatric Disorders, and Microglia Minocycline increases quality and longevity of chronic neural recordings.The efficacy of tetracyclines in peripheral and intracerebral prion infection.Tetracyclines affect prion infectivity.SK3 Channel Overexpression in Mice Causes Hippocampal Shrinkage Associated with Cognitive Impairments.Neuroprotective effects of compounds with antioxidant and anti-inflammatory properties in a Drosophila model of Parkinson's disease Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke.Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention Potential future neuroprotective therapies for neurodegenerative disorders and stroke.A novel target of action of minocycline in NGF-induced neurite outgrowth in PC12 cells: translation initiation [corrected] factor eIF4AI.The Effects of Chunghyul-Dan, an Agent of Korean Medicine, on a Mouse Model of Traumatic Brain Injury Cyclopentenone eicosanoids as mediators of neurodegeneration: a pathogenic mechanism of oxidative stress-mediated and cyclooxygenase-mediated neurotoxicity.Minocycline is cytoprotective in human trabecular meshwork cells and optic nerve head astrocytes by increasing expression of XIAP, survivin, and Bcl-2.HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities.Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseases Catalytic antioxidants and neurodegeneration

P2860

Q21129436-F3610B6D-528A-473E-B200-B069C5A7EC63 Q23916369-DE32D9A7-17C2-4518-950F-F9D6C2C17C52 Q24621854-3E972381-6D40-407C-B6AF-60054B493637 Q24630229-8582F05E-144E-4AE3-872C-38368853E408 Q24630245-98DE27C0-063A-4040-96A1-1CB796EEC564 Q24806826-88A11856-F384-4011-937A-6D6A1814C3E3 Q26747508-C413D8D9-2B75-4D27-9210-47A24161F36B Q26777952-FC57B30A-FB3B-4048-9A55-C70F3E965068 Q26859392-CDF74A63-9438-4D89-9CFB-6C1A13B970E7 Q26864400-8DB42635-0345-418C-A72B-3633C50EC785 Q27027973-F9C8F4D8-AB31-4712-9A03-5058A0883683 Q27342233-C3AEE7A7-0E14-4A00-91A5-71C76E6D1E35 Q27693871-FC62E3D4-6F04-4171-B883-D29B571F4C38 Q28079187-A7E89434-DA60-4767-A766-2DB05477A12F Q28260273-4048A4AA-8E98-4C1E-9A2D-F0CFA29AC8B5 Q28468677-C3C86F11-134D-43DB-9620-DAB84FDDEB9A Q28481316-A01F16CC-CC9C-4600-99E9-B7A8898CDA9F Q28574259-3D1472E0-087C-4D49-B9B1-2E5FA2D765F4 Q28576309-01E0E2B9-49EB-4593-BE9E-988B10067584 Q29248442-388585A3-FDA0-456A-AF6C-1E094320E352 Q30275056-4632064C-1626-4F2C-8FFC-1EB3E97B1030 Q30385588-D503324F-3AA2-478F-AD71-17692F20B6B9 Q30407150-80F37C70-A5B7-4524-97FB-1038CDEA0D58 Q30425537-85E4D6FC-058E-48BE-AB73-51BB02351839 Q30452038-AA09E2F0-B3DE-4B32-BA94-AF2FD0F1EB2C Q30496475-A1F10965-E1C0-479D-BA72-0BD7DD24822E Q30496598-64D1E158-6409-451F-9837-0A0B6507AC58 Q30531528-142F2D51-D256-472A-84C9-13EABD099AE8 Q30838734-8686FF4D-D85C-4C9D-B2DA-77382ADB02D8 Q33499111-3D8CA24D-1147-4DDC-924F-CF9D436A1492 Q33508929-A4676849-DB36-4CA6-8A3D-C73994106D57 Q33663970-2AD4EA4C-69A9-4A31-902F-47A0B885FC62 Q33687436-94F110B7-8E75-4B87-AA92-2FA15FA57FC8 Q33769000-B2648EB8-6EC1-4CF3-92EA-98EFAF46E4CF Q33823964-0C3CF153-13DD-4A01-9C01-5EEBC671E6ED Q33896920-5CAD4CCD-CD76-4DDE-A368-DE9E6569D498 Q34019667-57D9EC07-7477-4377-B433-804047743787 Q34037622-112F0913-8D01-4BCA-9BB4-2B2638545E31 Q34071942-76517CD4-5812-4A35-9283-8E7034AF072B Q34104938-D2EE6020-1C1B-4FB2-A632-CEC263C846E0

P2860

Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease

http://www.wikidata.org/entity/Q33952130

description

2001 nî lūn-bûn

@nan

2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Minocycline prevents nigrostri ...... P model of Parkinson's disease

@ast

Minocycline prevents nigrostri ...... P model of Parkinson's disease

@en

type

label

Minocycline prevents nigrostri ...... P model of Parkinson's disease

@ast

Minocycline prevents nigrostri ...... P model of Parkinson's disease

@en

prefLabel

Minocycline prevents nigrostri ...... P model of Parkinson's disease

@ast

Minocycline prevents nigrostri ...... P model of Parkinson's disease

@en

P1433

Q33952130-5E7B7376-D766-4EF0-AEB3-58812A90BAB3

P1476

Q33952130-BF61BA31-1E7A-42DB-94BA-2423FB232AE9

P2093

Q33952130-15A1594E-36C8-4E80-9509-542D17FCCA7E

Q33952130-1D635D09-3324-417D-916C-5953C491004F

Q33952130-2856945A-4A20-41B8-8292-54C024CD3D11

Q33952130-29669D2F-41AE-42E3-B0C2-790576B6BD21

Q33952130-2A4D0251-2629-43D4-BE40-3F71A1D992EB

Q33952130-70E236E9-0FA6-4145-A9A8-E358CA531099

Q33952130-72B82367-EB04-46A4-8871-CA928387BE89

Q33952130-8777C73E-485C-4104-B48D-C22665A2610C

Q33952130-98126860-4E83-44BD-A0CB-37A3A38D0B4F

Q33952130-B3DD9B8F-A303-4043-A316-2E916A94BA9B

P2860

Q33952130-0636B916-B6B0-4F47-8402-7F70B985E28E

Q33952130-120BDBED-A295-42C0-8439-CBBF58E5D481

Q33952130-1279C822-D419-4FF1-8798-C3E8E181E62F

Q33952130-13387656-3494-4E12-91AB-D41FF9853B48

Q33952130-1F9DA312-F9F5-46FB-9CC5-5363A695323C

Q33952130-2E7B30ED-B702-43D5-8F76-0CFDB525B3FD

Q33952130-2FC7015C-9FBA-4147-A942-EEEE8B3DFE88

Q33952130-3076C1E7-8159-4300-BC02-8EC176B5D9F9

Q33952130-4C6ED66A-7C9E-46BD-80B4-906CE02450D9

Q33952130-5325FA2A-7655-4DD8-A351-0D8CBAC1BA03

P304

Q33952130-EFD59699-4065-46B5-97F1-7FBB7D4BD8BA

P31

Q33952130-A2B3B9C1-A67B-4B3D-8138-7EB0B22C711D

P356

Q33952130-9C306FD9-0A3D-4336-AAD5-A4A513076E94

P407

Q33952130-BF069E7A-6C36-4E3E-B0AF-3792B8C559EE

P433

Q33952130-8850EAFB-193C-44B9-BBBB-E05E78EBC151

P478

Q33952130-45F5D310-B5B2-4B20-866E-2BAEDC01A7CE

P577

Q33952130-D8D8279D-2445-4851-BB6E-ECD8246903B2

P5875

Q33952130-9068DBE1-CB73-4767-80EE-C69BD527D930

P698

Q33952130-1C0FAD1B-70A1-43C5-B99B-90EBB3C3444F

P921

Q33952130-181D43ED-A456-4E65-B0E6-268BBCC86F58

Q33952130-7E9502B7-ABAF-4354-AE4E-53F85D5435FD

P932

Q33952130-0FDD2073-8ECD-4751-BF35-22631769D28F

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Minocycline prevents nigrostri ...... P model of Parkinson's disease

@en

P2093

D L Nelson

http://www.w3.org/2001/XMLSchema#string

E Chernet

http://www.w3.org/2001/XMLSchema#string

F Gao

http://www.w3.org/2001/XMLSchema#string

F P Bymaster

http://www.w3.org/2001/XMLSchema#string

K R Bales

http://www.w3.org/2001/XMLSchema#string

K W Perry

http://www.w3.org/2001/XMLSchema#string

L A Phebus

http://www.w3.org/2001/XMLSchema#string

L C Triarhou

http://www.w3.org/2001/XMLSchema#string

R C Dodel

http://www.w3.org/2001/XMLSchema#string

S Lin

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia

Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia

Experimental models of Parkinson's disease: insights from many models.

Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease.

New insights into the cause of Parkinson's disease.

p38 MAP kinase mediates bax translocation in nitric oxide-induced apoptosis in neurons.

A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window

N-methyl-D-aspartate receptor-mediated neuroprotection in cerebellar granule cells requires new RNA and protein synthesis.

Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity.

P304

14669-14674

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.251341998

http://www.w3.org/2001/XMLSchema#string

P407

P433

25

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P577

2001-11-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24483930

http://www.w3.org/2001/XMLSchema#string

P698

11724929

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

64739

http://www.w3.org/2001/XMLSchema#string